Advanced search

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

(2006) BRITISH JOURNAL OF CANCER. 94(4). p.481-485
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
DEMOLS, A, Marc Peeters, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ, and JL VAN LAETHEM. 2006. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: a Phase II Study.” British Journal of Cancer 94 (4): 481–485.
APA
DEMOLS, A., Peeters, M., POLUS, M., MARECHAL, R., GAY, F., MONSAERT, E., HENDLISZ, A., et al. (2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER, 94(4), 481–485.
Vancouver
1.
DEMOLS A, Peeters M, POLUS M, MARECHAL R, GAY F, MONSAERT E, et al. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER. NATURE PUBLISHING GROUP; 2006;94(4):481–5.
MLA
DEMOLS, A, Marc Peeters, M POLUS, et al. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: a Phase II Study.” BRITISH JOURNAL OF CANCER 94.4 (2006): 481–485. Print.
@article{332016,
  author       = {DEMOLS, A and Peeters, Marc and POLUS, M and MARECHAL, R and GAY, F and MONSAERT, ELS and HENDLISZ, A and VAN LAETHEM, JL},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  language     = {eng},
  number       = {4},
  pages        = {481--485},
  publisher    = {NATURE PUBLISHING GROUP},
  title        = {Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study},
  volume       = {94},
  year         = {2006},
}

Web of Science
Times cited: